A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid LeukemiaGabriel N. Mannis, Thomas G. Martin, Aaron C. Logan et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3